ABEONA THERAPEUTICS INC. Goodwill
ABEONA THERAPEUTICS INC. (ABEO) had Goodwill of $32.47 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2023-03-29
- 2021-09-30: Goodwill $32.47M.
- 2021-06-30: Goodwill $32.47M.
- 2021-03-31: Goodwill $32.47M.
- 2020-12-31: Goodwill $32.47M.
| Period end | Goodwill |
|---|---|
| 2021-09-30 | $32.47M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $32.47M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $32.47M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $32.47M 10-K · filed 2023-03-29 |
| 2020-09-30 | $32.47M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $32.47M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $32.47M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $32.47M 10-K · filed 2022-03-31 |
| 2019-09-30 | $32.47M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $32.47M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $32.47M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $32.47M 10-K · filed 2020-03-16 |
| 2018-09-30 | $32.47M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $32.47M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $32.47M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $32.47M 10-K · filed 2019-03-18 |
| 2017-09-30 | $32.47M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $32.47M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $32.47M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $32.47M 10-K · filed 2018-03-16 |
| 2016-09-30 | $32.47M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $32.47M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $32.47M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $32.47M 10-K · filed 2017-03-30 |
| 2015-09-30 | $38.95M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $38.95M 10-Q · filed 2015-08-14 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |